Introduction
============

Esophageal cancer typically occurs in the middle thoracic of the esophagus and is one of the leading causes of cancer-associated mortality in China ([@b1-ol-0-0-6127]). There are two distinct types of esophageal cancer, esophageal squamous cell carcinoma (ESCC), which may occur along the entire esophagus, and esophageal adenocarcinoma, which may develop due to short-segment gastro-esophageal reflux disease ([@b2-ol-0-0-6127]). However, the mechanisms underlying the development of ESCC have previously not been well demonstrated. The Chaoshan region has one of the highest incidences of esophageal cancer in China, and the age-standardized incidence rates in the Chaoshan area for ESCC were 74/100,000, which is \~10 times greater than the worldwide rate in 2014 ([@b3-ol-0-0-6127]--[@b5-ol-0-0-6127]). These findings indicate that there is a unique environment and/or genetic factors involved in the pathogenesis of ESCC.

Oxidative stress is an imbalance between the production of reactive oxygen species (ROS) and antioxidant defenses ([@b6-ol-0-0-6127]). The major mechanisms underlying the oxidative stress-mediated promotion of cancer have been previously demonstrated ([@b7-ol-0-0-6127],[@b8-ol-0-0-6127]). A certain mechanism involved oxidative stress-damaged DNA and led to cell transformation, which promoted cancer development ([@b8-ol-0-0-6127]). Another mechanism was induced oxidative stress, which activated numerous cell signaling pathways and may promote carcinogenesis ([@b8-ol-0-0-6127]). However, there are specific mechanisms that require further investigation. Chronic inflammation is another important risk factor associated with a number of human cancer subtypes, including colon adenocarcinoma and pancreatic cancer ([@b9-ol-0-0-6127],[@b10-ol-0-0-6127]). The association between inflammation and cancer has been clearly demonstrated in previous studies ([@b6-ol-0-0-6127],[@b9-ol-0-0-6127],[@b10-ol-0-0-6127]). However, further pathological evidence is required in order to support the results of these studies.

The present study investigated the hypothesis that oxidative stress is one of the driving forces of ESCC. The expression of 4-hydroxynonenal (4-HNE) in a large cohort of ESCC tissues obtained from patients living in Chaoshan was evaluated by immunohistochemistry (IHC) in order to determine the clinical and prognostic significance of 4-HNE in ESCC. Finally, the association of 4-HNE expression level and severity of inflammation in ESCC was determined.

Materials and methods
=====================

### ESCC tumor samples

The present study obtained 57 consecutive ESCC tumors from surgery, randomly selected from the First Affiliated Hospital of Shantou University Medical College (Shantou, China) from July 2000 to June 2012. All patients underwent potentially curative surgery without preoperative chemotherapy or radiotherapy. In this cohort, 46 patients were male and 11 were female; the age range was 40--75 years, with a median of 58 years. Follow-up data were available for all patients. The majority of patients (48, 84.2%) succumbed to the disease during the follow-up period (median, 33.6 months). The present study was approved by the Ethics Committee of the Medical College of Shantou University (Shantou, China). Written informed consent was obtained from all patients prior to enrollment in the present study.

### IHC

IHC staining was performed using the EnVision Labeled Peroxidase System (Dako; Agilent Technologies, Inc., Santa Clara, CA, USA), according to manufacturers protocol. Consecutive sections of tissue (4-µm thick) were obtained from each sample and deparaffinized in dimethyl benzene, rehydrated through a graded ethanol series and incubated with fresh 3% H~2~O~2~ for 10 min in order to inhibit endogenous peroxidase activity. The tissues were subsequently washed in PBS, and antigen retrieval was performed by microwave heating at 100°C for 20 min. Following incubation with 10 mmol/l citrate buffer (pH 6.0) for 20 min, primary antibodies against 4-HNE (\#ab48506; dilution, 1:75; Abcam, Cambridge, UK) were incubated at 4°C overnight. Subsequent to washing in PBS three times, immunostaining was visualized with a labeled streptavidin-biotin method using the Dako REAL™ EnVision™ Detection system, Peroxidase/3,3′-diaminobenzidine+, Rabbit/Mouse (1:200; catalog no. K5007; Dako; Agilent Technologies, Inc.) and included 20 min incubation with the biotinylated antibody and 20 min in streptavidin horseradish peroxidase, followed by counterstaining with 10% hematoxylin, all performed at room temperature. Images were captured using an IM50 microscope (Leica Microsystems GmbH, Wetzlar, Germany) at ×400 magnification. IHC staining was evaluated by two pathologists who were blinded to the clinical outcome, and concordance between the two pathologies was guaranteed.

For the analysis of 4-HNE immunostaining, the intensity and percentage of immunostained cells was determined, and scoring of 4-HNE immunostaining was performed. The percentage of positive cells in each case was categorized as: 0 (\<5% positive cells), 1+ (6--25% positive cells), 2+ (26--50% positive cells), 3+ (51--75% positive cells) or 4+ (\>75% positive cells). The staining intensity was categorized as 0--3+ as follows: 3+, intense positive stain; 2+, moderate positive stain; 1+, weak positive stain; 0, negative stain. The final scores were based on the multiplication of the percentage score and the intensity score, which ranged from 0 to 12. Tumors were considered to have low 4-HNE expression levels when they were assigned a score of 0--4, whereas tumors were considered to have high 4-HNE expression levels if they had a final score of ≥6.

### Statistical analysis

Data are expressed as the mean ± standard deviation. The prognostic significance of the expression of various markers was analyzed using the Kaplan-Meier test. The association between 4-HNE and clinical parameters was evaluated using the χ^2^ or Student\'s t-test. P≤0.05 was considered to indicate a statistically significant difference.

Results
=======

### Expression levels of 4-HNE in ESCC patient tissue samples

In order to determine the role of oxidative stress in esophageal tissues, the present study investigated the status of oxidative stress in esophageal epithelial tissues exhibiting various degrees of chronic inflammation. For identifying oxidative stress, 4-HNE is one of most bioactive and studied lipid peroxidation biomarkers ([@b11-ol-0-0-6127]). For the evaluation of the expression levels of 4-HNE in the cohort of ESCC tissue samples, the present study performed IHC on paraffin-embedded tissues. The immunoreactivity of 4-HNE was determined based on the presence of cytoplasmic staining, and was identified in the majority of ESCC tissue samples (40/57, 70.1%; [Fig. 1A, a and b](#f1-ol-0-0-6127){ref-type="fig"}). The staining was categorized as negative (n=17, 29.8%) if the staining score was 0, and positive if the staining score was \>0 (n=40, 70.2%). Furthermore, the expression level of 4-HNE was positive in 8/23 (34.8%) benign esophageal epithelial tissue samples. The remaining 15/23 (65.2%) tissue samples displayed no detectable cytoplasmic expression level of 4-HNE ([Fig. 1A, c and d](#f1-ol-0-0-6127){ref-type="fig"}). The esophageal carcinoma *in situ* tissues revealed relatively negative 4-HNE immunostaining in 6/11 cases (54.5%) and positive staining in 5/11 cases (45.5%; [Fig. 1A, e and f](#f1-ol-0-0-6127){ref-type="fig"}). The IHC score of 4-HNE is presented in [Fig. 1B](#f1-ol-0-0-6127){ref-type="fig"}. The final IHC score of ESCC tissues is significantly higher compared with that of benign esophageal epithelial tissues (P\<0.05); however, the score of 4-HNE in carcinoma *in situ* tissue samples is higher compared with that in benign tissues, but no significant difference was identified (P=0.067).

### Clinical significance of 4-HNE expression level in ESCC tissues

The present study investigated whether the expression level of 4-HNE determined by IHC was associated with various clinicopathological parameters, including gender, location and size of the tumor, lymph node metastasis, histologic grade, depth of tumor invasion and overall clinical stage. As summarized in [Table I](#tI-ol-0-0-6127){ref-type="table"}, the results revealed that the expression level of 4-HNE was associated with the clinical stage (P=0.043). Tissue samples with positive 4-HNE expression levels also exhibited an association with a late degree of clinical stage. The expression level of 4-HNE revealed no significant association with other clinicopathological parameters.

Clinical follow-up data were available for all patients included in the present study (median follow-up time, 33.6 months; range, 1--68 months). The survival data was analyzed by the Kaplan-Meier test. The overall survival time of patients with 4-HNE-positive tumors was significantly longer compared with that of patients with 4-HNE-negative tumors (30.7 vs. 10.9 months; P=0.029; [Fig. 2](#f2-ol-0-0-6127){ref-type="fig"}).

### Expression level of 4-HNE is associated with the severity of chronic inflammation in ESCC tissues

Oxidative stress has previously been reported to be an important factor in the promotion of ESCC carcinogenesis ([@b12-ol-0-0-6127]). Therefore, the present study hypothesized that the expression level of 4-HNE was associated with the stage of ESCC chronic inflammation of ESCC tissue samples. In order to support this hypothesis, the present study evaluated the status of chronic inflammation in esophageal tissues and revealed that chronic inflammation was positively associated with the level of dysplasia in esophageal epithelial tissues, indicating that inflammation is a potential factor promoting esophageal carcinogenesis ([Fig. 3A](#f3-ol-0-0-6127){ref-type="fig"}).

The present study determined the association of 4-HNE with the inflammation level in ESCC tissues. Based on the severity of chronic inflammation, 57 ESCC tissue samples were divided into negative, mild and severe subgroups. An increased level of staining of 4-HNE was identified in esophageal tissues that had an increased level of chronic inflammation ([Fig. 3B](#f3-ol-0-0-6127){ref-type="fig"}). The strongest immunostaining of 4-HNE was observed in severe dysplastic tissues accompanied with severe chronic inflammation ([Fig. 3C](#f3-ol-0-0-6127){ref-type="fig"}), indicating that oxidative stress is a potential factor promoting ESCC inflammation.

Discussion
==========

The present study evaluated the expression levels of 4-HNE in a cohort of ESCC patients and demonstrated that 4-HNE expression is significantly higher in ESCC tissues, compared with that in benign esophageal epithelial tissues. Furthermore, the 4-HNE expression level was significantly associated with the poorest clinical stage of ESCC. Patients with positive staining of 4-HNE revealed poorer clinical outcomes compared with patients with a negative 4-HNE expression.

ESCC is one of the most common cancer subtypes in China, particularly in the Chaoshan region ([@b13-ol-0-0-6127]). The rate of incidence of ESCC in Chaoshan is amongst the highest in China, indicating that there may be certain genetic and/or environmental factors contributing to ESCC carcinogenesis ([@b1-ol-0-0-6127]). A previous study revealed that tobacco smoking, and consumption of hot drinks and alcohol are established risk factors for ESCC ([@b14-ol-0-0-6127]). The potential mechanisms underlying these risk factors may induce endogenous metabolic reactions in cells and produce ROS, including superoxide anions (O~2~^−^), hydroxyl radicals (OH^•^) and organic peroxides ([@b15-ol-0-0-6127]). ROS serve various roles in cellular processes, and low concentrations of ROS have beneficial effect on cells including the promotion of wound healing and tissue repair, in addition to pathogen destruction ([@b16-ol-0-0-6127]).

However, the accumulation of ROS may induce oxidative stress to damaged cells and contribute to inflammation-induced tissue damage, carcinogenesis, diabetes, cardiovascular disease, Alzheimer\'s disease, Parkinson\'s disease and autoimmune diseases ([@b17-ol-0-0-6127]). Furthermore, the association between oxidative stress and inflammation has previously been demonstrated in numerous studies ([@b9-ol-0-0-6127],[@b10-ol-0-0-6127]). A previous study demonstrated that oxidative stress induces a number of diseases, including chronic inflammation and various cancer subtypes ([@b9-ol-0-0-6127]). Oxidative stress may induce DNA damage and increase the mutation rate of cells, and promote cell transformation ([@b8-ol-0-0-6127]). However, oxidative stress may also activate certain cell signaling pathways and contribute to cell survival, angiogenesis and metastasis ([@b9-ol-0-0-6127]). Oxidative stress may be involved in various phases of tumorigenesis, including cell survival, proliferation, invasion and chemoresistance ([@b9-ol-0-0-6127]). 4-HNE is considered to be a product of lipid peroxidation and an inducer of oxidative stress ([@b12-ol-0-0-6127]).

4-HNE is a major product of lipid peroxidation that forms covalent adducts with nucleophilic functional groups in macromolecules, including proteins, DNA and lipids ([@b18-ol-0-0-6127]). In previous studies, 4-HNE was identified to be involved in a number of degenerative diseases, including Alzheimer\'s disease, atherosclerosis and cancer ([@b19-ol-0-0-6127]--[@b21-ol-0-0-6127]). For example, the expression level of 4-HNE was increased in the blood and muscles of obese patients, compared with patients of a healthy weight ([@b22-ol-0-0-6127],[@b23-ol-0-0-6127]). However, the expression level of 4-HNE has not been extensively investigated in cancer tissues. The present study demonstrated that the expression level of 4-HNE is higher in ESCC tissues compared with that in benign esophageal epithelial and esophageal carcinoma *in situ* tissues, indicating that oxidative stress may be a driving force of ESCC carcinogenesis. In conclusion, the results of the present study suggested that 4-HNE may be highly expressed in ESCC tissues and that a high expression level of 4-HNE was associated with the severity of inflammation in ESCC. The present study provided evidence that oxidative stress may promote the tumorigenicity and inflammation of ESCC tissues.

![Heterogeneous 4-HNE expression level in ESCC. (A) IHC analysis was performed on formalin-fixed paraffin-embedded tissues, and the expression levels of 4-HNE were investigated in the cytoplasm. Based on the staining, tumors in the cohort were categorized into (a) 4-HNE-positive or (b) 4-HNE-negative in ESCC tissues; the normal epithelium was categorized into (c) 4-HNE-positive or (d) 4-HNE-negative; carcinoma *in situ* was categorized into (e) 4-HNE-positive or (f) 4-HNE-negative. (B) IHC score of 4-HNE expression in ESCC tissues *in situ* and benign tissues. IHC staining scale bar, 50 µm. \*P\<0.05. 4-HNE, 4-hydroxynonenal; ESCC, esophageal squamous cell carcinoma; IHC, immunohistochemistry.](ol-14-01-0035-g00){#f1-ol-0-0-6127}

![Kaplan-Meier analysis of 4-HNE expression level in esophageal squamous cell carcinoma patient samples. By performing the Kaplan-Meier test, the present study revealed a significant association between overall survival and the expression level of 4-HNE (P=0.029), when the two groups were defined as positive and negative. 4-HNE, 4-hydroxynonenal.](ol-14-01-0035-g01){#f2-ol-0-0-6127}

![Expression level of 4-HNE in ESCC tissues with a variety of inflammation severities. (A) The expression level of 4-HNE in (a) normal esophageal epithelial is negative and (b) the expression of carcinoma *in situ* tissues with inflammation is positive for 4-HNE. (c) In the same tissue, the expression level of 4-HNE is higher in epithelial tissues with inflammation compared with that of normal epithelial tissues. (B) Expression level of 4-HNE in ESCC tissues with a variety of inflammation severity. (a) Tissues with severe inflammation demonstrated a high expression level of 4-HNE, and (b) low 4-HNE expression level and (c) negative 4-HNE staining was identified in tissues with no inflammation. (C) The IHC score of 4-HNE was determined in ESCC tissue subgroups with a variety of inflammation severity. The IHC score of 4-HNE in severe inflammation is significantly higher compared with normal tissues. IHC staining scale bar, 50 µm. \*P\<0.05.](ol-14-01-0035-g02){#f3-ol-0-0-6127}

###### 

Association of 4-HNE expression level with various clinicopathological parameters in ESCC.

                            4-HNE expression level determined by IHC         
  ------------------- ----- ------------------------------------------ ----- -------
  Age (years)                                                                
    ≤57               28      6                                        22    0.248
    \>58              29    11                                         18    
  Gender                                                                     
    Male              46    12                                         34    0.275
    Female            11      5                                          6   
  Tumor site                                                                 
    Upper               6     4                                          2   0.770
    Middle            45    23                                         22    
    Lower               6     3                                          3   
  Differentiation                                                            
    Poor                4     3                                          1   0.555
    Intermediate      31    15                                         16    
    Well              22    10                                         12    
  Tumor size (cm)                                                            
    ≥5                38    13                                         25    0.370
    \<5               19      4                                        15    
  Depth of invasion                                                          
    T1-T2             48    13                                         35    0.428
    T3-T4               9     4                                          5   
  Lymph metastasis                                                           
    Yes               30      8                                        22    0.773
    No                27      9                                        18    
  Clinical stage                                                             
    1                   2     1                                          1   0.043
    2                 26    18                                           8   
    3                 27      8                                        19    
    4                   2     1                                          1   

4-HNE, 4-hydroxynonenal; ESCC, esophageal squamous cell carcinoma; IHC, immunohistochemistry.
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